glp 1 and histamine intolerance The Microbiome Mast Cell Activation Syndrome (MCAS)

Weight maintenance after GLP-1 medication depends far more on behaviour than dosage

However, sublingual semaglutide is not the same as FDA-approved oral semaglutide (Rybelsus), which uses a specialized absorption enhancer called SNAC

GLP-1 drugs strengthen those natural stop signals

The most common issues reported by patients across both formats include mild to moderate nausea, changes in bowel habits, and a reduced desire to eat

At her 1 month follow up appointment, only minimal improvement was noted

Both can contribute to allodynia in semaglutide users, and understanding them helps explain why the condition sometimes resolves on its own and sometimes requires intervention